Article
Gene Therapy for Chronic Granulomatous Disease: Current Status and Future Perspectives
27 Sept 2014
Abstract excerpt
Several Phase I/II clinical trials aiming at the correction of X-linked CGD by gene transfer into hematopoietic stem cells (HSCs) have demonstrated the therapeutic potential of gene modified autologous HSCs for the treatment of CGD. Resolution of therapy-resistant bacterial and fungal infections in liver, lung and spinal canal of CGD patients were clearly documented in all trials. However, clinical benefits were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
